|
For Immediate Release |
Contact: Jay Zager |
|
March 10, 2005 |
(860) 644-1551 |
GERBER SCIENTIFIC ANNOUNCES FISCAL 2005 THIRD QUARTER RESULTS
SOUTH WINDSOR, CT -- Gerber Scientific, Inc. (NYSE: GRB) today reported a loss for the three months ended January 31, 2005 of $0.02 per diluted share on revenue of $124.8 million compared with a loss of $0.05 per diluted share on revenue of $120.9 million for the three months ended January 31, 2004.
For the nine months ended January 31, 2005, the Company reported a loss of $0.03 per diluted share on revenue of $383.9 million compared with earnings of $0.09 per diluted share on revenue of $380.1 million for the nine months ended January 31, 2004.
Foreign currency translation had the effect of increasing revenue by approximately $5.3 million and $15.2 million in the fiscal 2005 third quarter and first nine months, respectively, over the fiscal 2004 comparable periods.Included in the results of both the fiscal 2005 third quarter and first nine months were tax benefits of $1.6 million. These benefits were attributable to the favorable impact of permanent tax benefits applied to a year-to-date pre-tax loss.
Gerber Scientific president and chief executive officer, Marc T. Giles said: "During the third quarter we made substantial progress toward completing the business reengineering plans fundamental to our turnaround strategy. While the third quarter is traditionally the weakest quarter in terms of revenue performance, we were able to record a modest operating profit. During the quarter, we completed the relocation of the Gerber Coburn manufacturing facility from Muskogee, Oklahoma to our Connecticut campus, with a reduction of over 150,000 square feet of production space. We anticipate further organization changes in the fourth quarter, primarily in our European operations."
Giles continued: "In addition to recording the modest operating profit, we generated in excess of $7.5 million of cash from operations. This was the sixth consecutive quarter of positive cash generation, with cumulative operating cash flow of about $43 million. As a result of this performance, we have been able to reduce our debt obligations, from about $90 million at May 9, 2003, the date of our refinancing, to $45.2 million at January 31, 2005. We remain committed to carefully managing our cash and to reducing our outstanding obligations as rapidly and prudently as possible."
Giles concluded: "We are encouraged by the long-term prospects for our business and are excited about the many new products that we will be launching in the coming quarters. These products, combined with our focus on continued improvements in our operating fundamentals, should position our company favorably as we move forward."
For additional information, including segment and order entry information, please see our quarterly report on Form 10-Q for the quarter ended January 31, 2005 filed with the Securities and Exchange Commission.
About Gerber Scientific, Inc.
Gerber Scientific, Inc. (http://www.gerberscientific.com) is a leading supplier of sophisticated automated manufacturing systems for sign making and specialty graphics, apparel and flexible materials, and ophthalmic lens processing. Headquartered in South Windsor, Connecticut, the Company operates through four businesses: Gerber Scientific Products, Spandex Ltd., Gerber Technology, and Gerber Coburn.
Forward-looking Statements:
Statements contained in this news release regarding the Company's expected financial condition, revenue, cash flow, operating results, restructuring and other charges, cost savings, operational efficiencies, debt reduction, and other potential benefits of its turnaround initiatives, business strategy and other planned events and expectations are forward-looking statements that involve risks and uncertainties. Actual future results or events may differ from these forward-looking statements. Readers are referred to the documents filed by the Company with the Securities and Exchange Commission, including the Company's quarterly reports on Form 10-Q for the quarters ended July 31, 2004 and October 31, 2004 and its annual report on Form 10-K for the fiscal year ended April 30, 2004, for a discussion of important risks that could cause actual results to differ from those contained or implied in the forward-looking statements. These risks include, but are not limited to, delays in the Company's new product development and commercialization, intense competition in markets for each of the Company's operating segments that could affect the Company's pricing decisions and the timing of product introductions, rapid technological advances that could cause the Company's inventory to exceed its needs or become obsolete, the Company's reliance on manufacturers or suppliers to supply inventory to the Company's specifications in a timely manner, non-recurring orders from significant customers, delays caused by facility relocations, the elimination of apparel trade quotas, fluctuations in currency exchange rates that could cause the Company's financial results to be volatile, and compliance with financial covenants associated with the Company's primary credit facilities. The Company expressly disclaims any obligation to update any of these forward-looking statements.
|
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES (Unaudited) |
||||||
|
|
Three Months Ended |
Nine Months Ended |
||||
|
In thousands (except per share amounts) |
2005 |
2004 |
2005 |
2004 |
||
|
Revenue: |
||||||
|
Product sales |
$ 107,899 |
$ 104,518 |
$ 333,848 |
$ 334,954 |
||
|
Service sales |
16,889 |
16,372 |
50,042 |
45,178 |
||
|
124,788 |
120,890 |
383,890 |
380,132 |
|||
|
Costs and Expenses: |
||||||
|
Cost of products sold |
75,378 |
70,631 |
227,757 |
225,967 |
||
|
Cost of services sold |
9,289 |
9,606 |
28,634 |
24,920 |
||
|
Selling, general and administrative |
32,461 |
30,547 |
100,660 |
96,294 |
||
|
Research and development |
6,509 |
6,021 |
18,730 |
18,647 |
||
|
Restructuring charges |
349 |
1,996 |
2,594 |
2,482 |
||
|
123,986 |
118,801 |
378,375 |
368,310 |
|||
|
Operating income |
802 |
2,089 |
5,515 |
11,822 |
||
|
Other expense, net |
(1,164) |
(1,355) |
(2,600) |
(3,508) |
||
|
Interest expense |
(1,576) |
(3,013) |
(5,326) |
(9,328) |
||
|
(Loss) before income taxes |
(1,938) |
(2,279) |
(2,411) |
(1,014) |
||
|
(Benefit) for income taxes |
(1,557) |
(1,134) |
(1,639) |
(2,994) |
||
|
Net (loss) earnings |
$ (381) |
$ (1,145) |
$ (772) |
$ 1,980 |
||
|
======= |
======= |
======= |
======= |
|||
|
(Loss) earnings per share of common stock: |
||||||
|
Basic |
$ (.02) |
$ (.05) |
$ (.03) |
$ .09 |
||
|
Diluted |
(.02) |
(.05) |
(.03) |
.09 |
||
|
Average shares outstanding: |
||||||
|
Basic |
22,263 |
22,205 |
22,255 |
22,190 |
||
|
Diluted |
22,263 |
22,205 |
22,255 |
22,378 |
||
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES (Unaudited) |
|||
|
|
January 31, 2005 |
April 30, 2004 |
|
| Assets: |
|||
| Current Assets: |
|||
|
Cash and cash equivalents |
$ 4,169 |
$ 6,371 |
|
Accounts receivable, net |
83,134 |
90,453 |
|
|
Inventories |
54,965 |
49,696 |
|
|
Prepaid expenses and other current assets |
12,169 |
11,307 |
|
|
154,437 |
157,827 |
||
| Property, Plant and Equipment, Net |
41,459 |
42,574 |
|
| Intangible Assets, Net |
59,809 |
59,010 |
|
| Deferred Income Taxes |
22,005 |
19,738 |
|
| Other Assets |
6,481 |
7,737 |
|
|
$ 284,191 |
$ 286,886 |
||
|
======= |
======= |
||
| Liabilities and Shareholders' Equity: |
|||
| Current Liabilities: |
|||
|
Current maturities of long-term debt |
$ 20,704 |
$ 12,509 |
|
|
Accounts payable |
38,755 |
43,397 |
|
|
Accrued and other liabilities |
51,390 |
46,135 |
|
|
110,849 |
102,041 |
||
| Noncurrent Liabilities: |
|||
|
Long-term debt |
24,495 |
46,512 |
|
|
Other long-term liabilities |
23,340 |
20,731 |
|
|
47,835 |
67,243 |
||
| Shareholders' Equity |
125,507 |
117,602 |
|
|
$ 284,191 |
$ 286,886 |
||
|
======= |
======= |
||